文献速递瓣膜外科

Sorin Soprano主动脉生物瓣的长期耐久性:瑞典全国性研究

Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve-A Swedish Nationwide Study.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该瑞典全国性队列纳入2005至2013年接受Sorin Soprano主动脉生物瓣置换的1054例患者,平均随访8.6年。结果显示15年严重结构性瓣膜 deterioration累积发生率达22.1%,相关再干预累积发生率为11.5%,提示该瓣膜长期耐久性较差,需加强超声监测。

要点

  • Soprano瓣15年严重结构性瓣膜 deterioration累积发生率为22.1%。
  • 15年瓣膜 deterioration相关再干预累积发生率为11.5%。
  • 术后30天死亡率为3.8%,需对植入该瓣患者加强超声随访。

核心结论

  • Soprano生物瓣长期严重结构性瓣膜 deterioration及再干预发生率较高,建议加强临床警惕和超声监测。

研究设计与样本

  • 瑞典全国性队列研究,纳入2005至2013年所有接受Soprano主动脉生物瓣置换的患者,共1054例,平均年龄73.3岁。

主要发现

  • 平均随访8.6±4.5年期间,206例(19.5%)发生严重结构性瓣膜 deterioration。
  • 严重结构性瓣膜 deterioration在1、5、7、10、15年的累积发生率分别为0.5%、3.1%、7.4%、13.7%、22.1%。
  • 结构性瓣膜 deterioration相关再干预在1、5、7、10、15年的累积发生率分别为0%、0.9%、3.0%、7.2%、11.5%。
  • 30天死亡率为3.8%。

关键数值与推荐

  • 采用标准化指南评估超声心动图数据以判定严重结构性瓣膜 deterioration。
  • Soprano生物瓣占所有植入生物瓣的9.5%。
  • 手术时年龄≤65岁者占14.0%。

临床怎么用

  • 对植入Soprano主动脉生物瓣的患者应提高临床警惕,并考虑更频繁的超声心动图监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Structural valve deterioration is an inherent limitation of bioprosthetic valves; however, the time it takes to develop varies depending on the valve model. The Sorin Soprano aortic bioprosthetic valve (Sorin Group/LivaNova, Milan, Italy) lacks reported long-term results. This study aims to establish the long-term durability of this bioprosthetic valve in a nationwide cohort. METHODS: All patients who had received the Soprano bioprosthesis during aortic valve replacement in Sweden between 2005 and 2013 were included in the study. Patient characteristics, outcomes, and echocardiographic data were collected using national registries and electronic medical records. Standardized guidelines were used to assess echocardiographic data for the presence of severe structural valve deterioration. RESULTS: A total of 1054 patients (mean age 73.3 years) were included, with 14.0% being ≤65 years at surgery. The Soprano bioprosthesis represented 9.5% of all implanted bioprostheses. During a mean follow-up of 8.6 ± 4.5 years, 206 patients (19.5%) developed severe structural valve deterioration. The cumulative incidence of severe structural valve deterioration at 1, 5, 7, 10, and 15 years was 0.5%, 3.1%, 7.4%, 13.7%, and 22.1%, respectively, in the overall population. The cumulative incidence of structural valve deterioration-related reinterventions at 1, 5, 7, 10, and 15 years was 0%, 0.9%, 3.0%, 7.2%, and 11.5%, respectively. The 30-day mortality rate was 3.8%. CONCLUSIONS: The Soprano bioprosthesis demonstrates high long-term rates of severe structural valve deterioration and deterioration-related reinterventions. These findings suggest the need for increased clinical vigilance and for more frequent echocardiographic monitoring in patients having received this bioprosthetic valve.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Hökfelt G, Clarelin A, Höglund M, et al. Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve-A Swedish Nationwide Study. Eur J Cardiothorac Surg. 2026. PMID: 41428413. doi:10.1093/ejcts/ezaf469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。